Get started
Author

Yangyi Bao

Antitumor effector B cells directly kill tumor cells via the Fas/FasL pathway and are regulated by IL‐10
2014 · Huimin Tao, Lin Lu, et al. · European Journal of Immunology · 114
PDF
Therapeutic Efficacy of Cancer Stem Cell Vaccines in the Adjuvant Setting
2016 · Yangyang Hu, Lin Lu, et al. · Cancer Research · 85
Humanized CD7 nanobody-based immunotoxins exhibit promising anti-T-cell acute lymphoblastic leukemia potential
2017 · Yuan Yu, Jialu Li, et al. · International Journal of Nanomedicine · 74
PDF
Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody
2017 · Ying Chen, Fengtao You, et al. · Oncotarget · 51
PDF
HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia
2017 · Mei Guo, Nelson J. Chao, et al. · JAMA Oncology · 46
PDF
IL-2 augments the therapeutic efficacy of adoptively transferred B cells which directly kill tumor cells via the CXCR4/CXCL12 and perforin pathways
2016 · Yang Xia, Huimin Tao, et al. · Oncotarget · 35
PDF
Abstract A014: Phase I clinical trial with PD-1/MUC1 CAR-pNK92 immunotherapy
2019 · Qiao Li, Yi Wang, et al. · Cancer Immunology Research · 21
HER2-targeted antibody-drug conjugate induces host immunity against cancer stem cells
2021 · Leiming Xia, Lu Wen, et al. · Cell chemical biology · 18
PDF
Thioridazine Sensitizes Esophageal Carcinoma Cell Lines to Radiotherapy-Induced Apoptosis In Vitro and In Vivo
2016 · Hongxia Li, Li Juan, et al. · Medical Science Monitor · 17
PDF
Efficacy and safety of MIL60 compared with bevacizumab in advanced or recurrent non-squamous non-small cell lung cancer: a phase 3 randomized, double-blind study
2021 · Rui Wan, Xiaorong Dong, et al. · EClinicalMedicine · 14
PDF
Synergistic Inhibition of Thalidomide and Icotinib on Human Non-Small Cell Lung Carcinomas Through ERK and AKT Signaling
2018 · Xiang Sun, Yang Xu, et al. · Medical Science Monitor · 13
The clinical study on treatment of CD19‐directed chimeric antigen receptor‐modified T cells in a case of refractory Richter syndrome
2019 · Leiming Xia, Yi Wang, et al. · Cancer Medicine · 7
PDF
[Mechanism of Killing Effect of Thioridazine on Human Lung Cancer PC9 Cells].
2015 · Li Gong, Yi Wang, et al. · Europe PMC (PubMed Central) · 7
Abstract CT041: The clinical study on CD19-directed chimeric antigen receptor-modified T cells in patient with Richter Syndrome
2017 · Leiming Xia, Qian Chen, et al. · Cancer Research · 6
[Thioridazine Sensitizes Apoptotic Effect of TRAIL in Human Lung Cancer PC9 Cells Through ER Stress Mediated Up-regulation of DR5].
2017 · Juan Li, Yi Wang, et al. · Europe PMC (PubMed Central) · 5
Microtransplantation Improved Outcome in Elderly Acute Myeloid Leukemia Patients - Report from China Microtransplantation Cooperative Group
2015 · Mei Guo, Jianyong Li, et al. · Blood · 3
[miR-181b-5p promotes cell proliferation and induces apoptosis in human acute myeloid leukemia by targeting PAX9].
2023 · Bin Li, Qianshan Tao, et al. · PubMed · 2
Abstract 3803: Synergistic inhibition of thioridazine combined with carboplatin on triple negative breast cancer by targeting cancer stem cells
2020 · Yi Wang, Leiming Xia, et al. · Cancer Research · 1
Thioridazine Enhances TRAIL Cytotoxicity in Human Myeloid Leukemic Cells By up-Regulating DR5 and Modulating PI3K-AKT-NF-Kb Pathway
2015 · Yi Wang, Yangyi Bao, et al. · Blood · 1
Abstract 1340: Antitumor effector B cells directly kill tumor cells involving the CXCL12/CXCR4 pathway and their therapeutic efficacy is enhanced by IL-2
2015 · Yang Xia, Huimin Tao, et al. · Cancer Research · 1
Clinical research of advanced non-small cell lung cancer patients treated with CIK cell combined with chemotherapy
2012 · Yangyi Bao · Anhui Medical and Pharmaceutical Journal · 1
Abstract CT150: Humanized CD19 CAR-T cells in the treatment of relapsed and refractory diffuse large B-cell lymphoma: A case report
2021 · Tan Li, Yi Wang, et al. · Cancer Research
Abstract 4981: HER2-targeted antibody drug conjugates (ADCs) induce host immunity against cancer stem cells and are enhanced by anti-PD-L1
2019 · Leiming Xia, Lu Wen, et al. · Cancer Research
Abstract 4981: HER2-targeted antibody drug conjugates (ADCs) induce host immunity against cancer stem cells and are enhanced by anti-PD-L1
2019 · Leiming Xia, Lu Wen, et al. · Immunology
Abstract CT060: A clinical study on CD33-directed chimeric antigen receptormodified NKcells in patient with refractory or relapsed acute myeloid leukemia
2018 · Leiming Xia, Xiang Sun, et al. · Cancer Research
Works count: 35
Citation count: 522
H-index: 11
I10-index: 11
Year
Topic
Type